Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunovant, Inc.

15.80
-0.0600-0.38%
Post-market: 15.800.00000.00%17:04 EDT
Volume:1.91M
Turnover:30.09M
Market Cap:2.70B
PE:-5.79
High:16.04
Open:16.04
Low:15.44
Close:15.86
Loading ...
Oct 05, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Sep 29, 2023

Major Issues Report

Form 8-K - Current report
Sep 28, 2023

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Sep 27, 2023

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Sep 26, 2023

Major Issues Report

Form 8-K - Current report
Aug 23, 2023

Major Issues Report

Form 8-K - Current report
Aug 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2023

Major Issues Report

Form 8-K - Current report
May 22, 2023

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
May 22, 2023

Major Issues Report

Form 8-K - Current report
Apr 05, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 27, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 03, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 03, 2023

Major Issues Report

8-K - Current report
Feb 03, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jan 09, 2023

Major Issues Report

8-K - Current report
Dec 08, 2022

Major Issues Report

8-K - Current report
Dec 05, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 02, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals